Postmarket Regulations Stricter For Devices Than for Drugs

Devices & Diagnostics Letter
KEYWORDS CDRH / FDA
A A
Federal device postmarket authorities are "far more extensive than for prescription drugs," and the FDA and CDRH are using their authorities to maintain continued device safety, Janet Trunzo, vice president of technology and regulatory affairs at AdvaMed, said.

To View This Article:

Login

Subscribe To Devices & Diagnostics Letter